• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用iRS平台测量α-突触核蛋白错误折叠作为帕金森病的液体生物标志物。

Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platform.

作者信息

Schuler Martin, Gerwert Grischa, Mann Marvin, Woitzik Nathalie, Langenhoff Lennart, Hubert Diana, Duman Deniz, Höveler Adrian, Galkowski Sandy, Simon Jonas, Denz Robin, Weber Sandrina, Kwon Eun-Hae, Wanka Robin, Kötting Carsten, Güldenhaupt Jörn, Beyer Léon, Tönges Lars, Mollenhauer Brit, Gerwert Klaus

机构信息

Center for Protein Diagnostics (PRODI), Ruhr-University Bochum, Bochum, Germany.

Department of Biophysics, Ruhr-University Bochum, Bochum, Germany.

出版信息

EMBO Mol Med. 2025 Apr 25. doi: 10.1038/s44321-025-00229-z.

DOI:10.1038/s44321-025-00229-z
PMID:40281305
Abstract

Misfolding and aggregation of alpha-synuclein (αSyn) play a key role in the pathophysiology of Parkinson's disease (PD). Despite considerable advances in diagnostics, an early and differential diagnosis of PD still represents a major challenge. We innovated the immuno-infrared sensor (iRS) platform for measuring αSyn misfolding. We analyzed cerebrospinal fluid (CSF) from two cohorts comprising PD cases, atypical Parkinsonian disorders, and disease controls. We obtained an AUC of 0.90 (n = 134, 95% CI 0.85-0.96) for separating PD/MSA from controls by determination of the αSyn misfolding by iRS. Using two thresholds divided individuals as unaffected/affected by misfolding with an intermediate area in between. Comparing the affected/unaffected cases, controls versus PD/MSA cases were classified with 97% sensitivity and 92% specificity. The spectral data revealed misfolding from an α-helical/random-coil αSyn in controls to β-sheet enriched αSyn in PD and MSA cases. Moreover, a first subgroup analysis implied the potential for patient stratification in clinically overlapping cases. The iRS, directly measuring all αSyn conformers, is complementary to the αSyn seed-amplification assays (SAAs), which however only amplify seeding competent conformers.

摘要

α-突触核蛋白(αSyn)的错误折叠和聚集在帕金森病(PD)的病理生理学中起关键作用。尽管在诊断方面取得了相当大的进展,但PD的早期和鉴别诊断仍然是一项重大挑战。我们创新了用于测量αSyn错误折叠的免疫红外传感器(iRS)平台。我们分析了来自两个队列的脑脊液(CSF),这些队列包括PD病例、非典型帕金森氏症和疾病对照。通过iRS测定αSyn错误折叠,我们在区分PD/MSA与对照时获得了0.90的曲线下面积(AUC)(n = 134,95% CI 0.85 - 0.96)。使用两个阈值将个体分为未受错误折叠影响/受错误折叠影响,中间有一个中间区域。比较受影响/未受影响的病例,对照与PD/MSA病例的分类敏感性为97%,特异性为92%。光谱数据显示,从对照中α-螺旋/无规卷曲的αSyn到PD和MSA病例中富含β-折叠的αSyn发生了错误折叠。此外,首次亚组分析表明在临床重叠病例中进行患者分层具有潜力。iRS直接测量所有αSyn构象体,是αSyn种子扩增检测(SAA)的补充,然而SAA仅扩增具有种子形成能力的构象体。

相似文献

1
Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platform.使用iRS平台测量α-突触核蛋白错误折叠作为帕金森病的液体生物标志物。
EMBO Mol Med. 2025 Apr 25. doi: 10.1038/s44321-025-00229-z.
2
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.独立的α-突触核蛋白种子扩增检测方法对早期帕金森病的高诊断性能。
Acta Neuropathol Commun. 2021 Nov 6;9(1):179. doi: 10.1186/s40478-021-01282-8.
3
Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.通过检测脑脊液中α-突触核蛋白错误折叠聚集体开发帕金森病的生化诊断方法。
JAMA Neurol. 2017 Feb 1;74(2):163-172. doi: 10.1001/jamaneurol.2016.4547.
4
Association between the Amplification Parameters of the α-Synuclein Seed Amplification Assay and Clinical and Genetic Subtypes of Parkinson's Disease.α-突触核蛋白种子扩增试验的扩增参数与帕金森病临床及基因亚型之间的关联
Mov Disord. 2025 Feb;40(2):305-314. doi: 10.1002/mds.30085. Epub 2024 Dec 18.
5
Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease.对比研究脑脊液α-突触核蛋白种子聚合分析在帕金森病诊断中的应用。
Mov Disord. 2019 Apr;34(4):536-544. doi: 10.1002/mds.27646. Epub 2019 Mar 6.
6
Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.用于帕金森病和路易体痴呆症各种生物样本的简化α-突触核蛋白实时无细胞扩增检测法
Acta Neuropathol Commun. 2021 Apr 7;9(1):62. doi: 10.1186/s40478-021-01175-w.
7
Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease?脑脊液中α-突触核蛋白的定量检测:这个生物标志物对帕金森病的理想程度如何?
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S76-9. doi: 10.1016/S1353-8020(13)70020-8.
8
Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.从孤立性快速眼动睡眠行为障碍和帕金森病患者的脑脊液中准确检测 α-突触核蛋白种子在 DeNovo 帕金森(DeNoPa)队列中的研究。
Mov Disord. 2023 Apr;38(4):567-578. doi: 10.1002/mds.29329. Epub 2023 Feb 13.
9
CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.脑脊液 α-突触核蛋白和 UCH-L1 在帕金森病和非典型帕金森综合征中的水平。
Parkinsonism Relat Disord. 2014 Apr;20(4):382-7. doi: 10.1016/j.parkreldis.2014.01.011. Epub 2014 Jan 22.
10
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's disease.一种定量的路易小体特异性α-突触核蛋白种子扩增检测法作为帕金森病的病情进展标志物
Acta Neuropathol. 2025 Feb 20;149(1):20. doi: 10.1007/s00401-025-02853-y.

本文引用的文献

1
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.神经元α-突触核蛋白病综合分期系统在PPMI、帕萨迪纳和SPARK基线队列中的表现。
NPJ Parkinsons Dis. 2024 Sep 27;10(1):178. doi: 10.1038/s41531-024-00789-w.
2
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease.路易体病理会加重阿尔茨海默病患者的脑代谢低下和认知能力下降。
Nat Commun. 2024 Sep 14;15(1):8061. doi: 10.1038/s41467-024-52299-1.
3
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification.
改进 α-突触核蛋白种子扩增测定法的方案:分析预分析和分析变量,并确定种子定量的候选参数。
Clin Chem Lab Med. 2024 Mar 11;62(10):2001-2010. doi: 10.1515/cclm-2023-1472. Print 2024 Sep 25.
4
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria.帕金森病的生物学分类:SynNeurGe 研究诊断标准。
Lancet Neurol. 2024 Feb;23(2):191-204. doi: 10.1016/S1474-4422(23)00404-0.
5
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.神经元α-突触核蛋白病的生物学定义:建立研究用综合分期系统。
Lancet Neurol. 2024 Feb;23(2):178-190. doi: 10.1016/S1474-4422(23)00405-2.
6
The pathogenesis of Parkinson's disease.帕金森病的发病机制。
Lancet. 2024 Jan 20;403(10423):293-304. doi: 10.1016/S0140-6736(23)01478-2.
7
The epidemiology of Parkinson's disease.帕金森病的流行病学。
Lancet. 2024 Jan 20;403(10423):283-292. doi: 10.1016/S0140-6736(23)01419-8.
8
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases.α-突触核蛋白 PET 示踪剂[18F]ACI-12589 可将多系统萎缩与其他神经退行性疾病区分开来。
Nat Commun. 2023 Oct 27;14(1):6750. doi: 10.1038/s41467-023-42305-3.
9
α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.α-突触核蛋白菌株及其与帕金森病、多系统萎缩和路易体痴呆的关系。
Int J Mol Sci. 2023 Jul 28;24(15):12134. doi: 10.3390/ijms241512134.
10
Cognitive effects of Lewy body pathology in clinically unimpaired individuals.路易体病在临床无明显障碍个体中的认知影响。
Nat Med. 2023 Aug;29(8):1971-1978. doi: 10.1038/s41591-023-02450-0. Epub 2023 Jul 18.